Cargando…
The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2
Sequencing of primary colorectal tumors has identified a gene fusion in approximately 3% of colorectal cancer patients of the VTI1A and TCF7L2 genes, encoding a VTI1A-TCF4 fusion protein containing a truncated TCF4. As dysregulation of the Wnt signaling pathway is associated with colorectal cancer d...
Autores principales: | Davidsen, Johanne, Larsen, Sylvester, Coskun, Mehmet, Gögenur, Ismail, Dahlgaard, Katja, Bennett, Eric Paul, Troelsen, Jesper Thorvald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033461/ https://www.ncbi.nlm.nih.gov/pubmed/29975781 http://dx.doi.org/10.1371/journal.pone.0200215 |
Ejemplares similares
-
CDX2 regulates interleukin‐33 gene expression in intestinal epithelial cells (LS174T)
por: Larsen, Sylvester, et al.
Publicado: (2021) -
HNF4α and CDX2 Regulate Intestinal YAP1 Promoter Activity
por: Larsen, Sylvester, et al.
Publicado: (2019) -
CDX2 expression and perioperative patient serum affects the adhesion properties of cultured colon cancer cells
por: Davidsen, Johanne, et al.
Publicado: (2020) -
Intestinal regulation of suppression of tumorigenicity 14 (ST14) and serine peptidase inhibitor, Kunitz type -1 (SPINT1) by transcription factor CDX2
por: Danielsen, E. Thomas, et al.
Publicado: (2018) -
Precise integration of inducible transcriptional elements (PrIITE) enables absolute control of gene expression
por: Pinto, Rita, et al.
Publicado: (2017)